New drug extends lives for pancreatic cancer patients but isn't a cure

A newly developed treatment, daraxonrasib, has shown promise in extending the lives of pancreatic cancer patients, potentially doubling their remaining years. However, the drug does not offer a cure and is only effective if the cancer is treated early.